A.J. Rice

Stock Analyst at UBS

(4.22)
# 395
Out of 4,877 analysts
238
Total ratings
63.06%
Success rate
9.76%
Average return

Stocks Rated by A.J. Rice

Cross Country Healthcare
May 13, 2025
Maintains: Neutral
Price Target: $19$17
Current: $13.18
Upside: +25.19%
AMN Healthcare Services
May 13, 2025
Maintains: Neutral
Price Target: $30$26
Current: $21.99
Upside: +15.96%
Pediatrix Medical Group
May 12, 2025
Maintains: Neutral
Price Target: $19$16
Current: $14.32
Upside: +11.73%
Aveanna Healthcare Holdings
May 9, 2025
Maintains: Sell
Price Target: $4.5$5
Current: $5.00
Upside: -
BXP, Inc.
May 5, 2025
Maintains: Neutral
Price Target: $80$68
Current: $68.12
Upside: -0.18%
Service Corporation International
May 2, 2025
Maintains: Buy
Price Target: $90$88
Current: $82.16
Upside: +7.11%
Tenet Healthcare
Apr 30, 2025
Maintains: Buy
Price Target: $217$230
Current: $177.43
Upside: +29.63%
Option Care Health
Apr 30, 2025
Upgrades: Buy
Price Target: $38$40
Current: $31.92
Upside: +25.31%
Healthcare Services Group
Apr 24, 2025
Upgrades: Buy
Price Target: $12$15
Current: $15.53
Upside: -3.41%
Community Health Systems
Feb 20, 2025
Maintains: Neutral
Price Target: $4.8$4.1
Current: $3.47
Upside: +18.16%
Maintains: Buy
Price Target: $22$30
Current: $22.27
Upside: +34.71%
Maintains: Neutral
Price Target: $40$21
Current: $15.25
Upside: +37.70%
Upgrades: Buy
Price Target: $79$80
Current: $56.65
Upside: +41.22%
Initiates: Buy
Price Target: $175
Current: $150.79
Upside: +16.06%
Maintains: Buy
Price Target: $605$555
Current: $395.76
Upside: +40.24%
Initiates: Buy
Price Target: $38
Current: $22.56
Upside: +68.44%
Initiates: Buy
Price Target: $50
Current: $12.95
Upside: +286.10%
Maintains: Buy
Price Target: $247$267
Current: $188.94
Upside: +41.31%
Upgrades: Neutral
Price Target: $9.5
Current: $7.88
Upside: +20.56%
Maintains: Outperform
Price Target: $450$485
Current: $727.74
Upside: -33.36%
Reiterates: Outperform
Price Target: $95
Current: $23.49
Upside: +304.43%
Maintains: Outperform
Price Target: $311$316
Current: $389.53
Upside: -18.88%
Maintains: Outperform
Price Target: $125$96
Current: $69.58
Upside: +37.97%
Maintains: Outperform
Price Target: $62$73
Current: $120.42
Upside: -39.38%
Maintains: Outperform
Price Target: $635$575
Current: $252.58
Upside: +127.65%
Upgrades: Neutral
Price Target: $38
Current: $21.72
Upside: +74.95%
Maintains: Outperform
Price Target: $590$610
Current: $326.14
Upside: +87.04%
Maintains: Outperform
Price Target: $308$305
Current: $264.26
Upside: +15.42%
Maintains: Neutral
Price Target: $64$79
Current: $164.40
Upside: -51.95%
Maintains: Outperform
Price Target: $350$410
Current: $306.29
Upside: +33.86%
Maintains: Neutral
Price Target: $43$37
Current: $9.42
Upside: +292.78%
Maintains: Neutral
Price Target: $158$143
Current: $179.33
Upside: -20.26%
Maintains: Neutral
Price Target: $52$43
Current: $11.49
Upside: +274.24%
Maintains: Outperform
Price Target: $181$182
Current: $96.41
Upside: +88.79%
Maintains: Outperform
Price Target: $300$270
Current: $334.39
Upside: -19.26%
Downgrades: Underperform
Price Target: $0.57
Current: $29.80
Upside: -98.09%